Was COVID-19 bio engineered?
What do you think:
‘’’It spontaneously occurred in a seafood market? Or it was created in a level-4 bio lab located literally one block away from said seafood market, where previous bio leaks have happened and whose scientists were studying the following:’’’
-Bats infected with genetically engineered Coronavirus.
-Coronavirus infected Bats.
-Chimeric bio-engineered viruses.
A small sampling of papers published prior to COVID-19:
‘’’Title: Methods and compositions for chimeric coronavirus spike proteins.’’’
‘’’Title: Manipulation of the Coronavirus Genome Using Targeted RNA Recombination with Interspecies Chimeric Coronaviruses.’’’
‘’’Title: Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats.’’’
This study increased our understanding of the genetic diversity of the SL-CoVs carried by bats and also provided a new perspective to study the possibility of cross-species transmission of SL-CoVs using suckling rats as an animal model.
‘’’Title: A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant.’’’
We introduced the SARS S glycoprotein ectodomain with the Y436H substitution into the BtCoV HKU5 genome (BtCoV HKU5-SE), and a recombinant chimeric virus was isolated that was capable of productive infection in culture and in young and aged BALB/c mice….
‘’’Title: Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China.’’’
Researchers, trying to prove that animals such pangolins are the missing link between bats and human for coronavirus transmission, constructed a chimeric coronavirus, substituting parts of the RDB of Bat coronavirus RaTG13 or KP876546 or similar with sequences from pangolins that better binds to ACE2.
‘’’Title: Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin.’’’
Combined HIV with the ACE2 molecules of human, civet, or horseshoe bat. Constructed chimeras by inserting SARS. The chimera gained ability to enter cells via human ACE2